Breaking News Instant updates and real-time market news.

RMD

ResMed

$117.03

-0.185 (-0.16%)

16:06
01/24/19
01/24
16:06
01/24/19
16:06

ResMed reports Q2 EPS $1.00, consensus 95c

Reports Q2 revenue $651.1M, consensus $672.91M. Q2 Gross Margin expanded 70bps to 58.9%.

  • 24

    Jan

  • 29

    Jan

  • 30

    Jan

RMD ResMed
$117.03

-0.185 (-0.16%)

10/26/18
FBCO
10/26/18
UPGRADE
FBCO
Outperform
ResMed upgraded to Outperform from Neutral at Credit Suisse
11/19/18
PIPR
11/19/18
NO CHANGE
Target $290
PIPR
Overweight
Mobi looks 'underwhelming,' investors should buy Inogen, says Piper Jaffray
After speaking with an "expert in the field" who got a firsthand look at ResMed's (RMD) Mobi device, Piper Jaffray analyst JP McKim tells investors to buy the recent pullback in shares of Inogen (INGN). Mobi has been a risk to Inogen's stock over the last year plus, McKim writes. However, he says the specs of the device "were a bit lower" than he had expected, especially on the flow rate. The product is not quite a "me too" to current products on the market and is a bit inferior to current models, so the ResMed brand and warranty will need to carry it in the marketplace, according to the analyst. He does not think Mobi will be overly impactful to Inogen's business. McKim calls Mobi's details "underwhelming" and keeps an Overweight rating on Inogen with a $290 price target.
12/10/18
BMOC
12/10/18
UPGRADE
Target $127
BMOC
ResMed upgraded to Outperform from Market Perform at BMO Capital
BMO Capital analyst Joanne Wuensch upgraded ResMed to Outperform and raised her price target to $127 from $109. The analyst cites the company's transition from being a sleep apnea company to "one of full inter-connectivity", with added benefits of the recent acquisitions and product launches. Wuensch expects 2019 to be a positive year for ResMed as it further integrates MatrixCare and Propeller Health while also launching its MobizCOPD device and generates additional operating leverage.
01/23/19
DBAB
01/23/19
DOWNGRADE
DBAB
Hold
ResMed downgraded to Hold from Buy at Deutsche Bank

TODAY'S FREE FLY STORIES

MTSC

MTS Systems

$56.33

-0.13 (-0.23%)

07:18
05/20/19
05/20
07:18
05/20/19
07:18
Recommendations
MTS Systems analyst commentary  »

MTS Systems price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTS

Akoustis

$7.39

-0.62 (-7.74%)

07:17
05/20/19
05/20
07:17
05/20/19
07:17
Hot Stocks
Akoustis announces shipments, production order for 3.8GHz filters »

Akoustis announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

AZN

AstraZeneca

$37.80

0.02 (0.05%)

07:16
05/20/19
05/20
07:16
05/20/19
07:16
Hot Stocks
AstraZeneca reports data from Novel START trial of Symbicort »

New data from Novel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 20

    Jun

DE

Deere

$134.82

-11.15 (-7.64%)

07:15
05/20/19
05/20
07:15
05/20/19
07:15
Recommendations
Deere analyst commentary  »

Deere price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

PDCE

PDC Energy

$36.67

-0.55 (-1.48%)

07:13
05/20/19
05/20
07:13
05/20/19
07:13
Hot Stocks
PDC Energy CEO sends letter to shareholders, encourages white proxy card vote »

PDC Energy mailed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

HEI

Heico

07:11
05/20/19
05/20
07:11
05/20/19
07:11
Recommendations
Heico analyst commentary  »

Heico price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 29

    May

  • 05

    Jun

MU

Micron

$36.06

-1.37 (-3.66%)

07:11
05/20/19
05/20
07:11
05/20/19
07:11
Recommendations
Micron analyst commentary  »

Micron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

CLI

Mack-Cali Realty

$22.92

-0.12 (-0.52%)

07:10
05/20/19
05/20
07:10
05/20/19
07:10
Hot Stocks
Mack-Cali Realty recommends stockholders vote the WHITE proxy card »

Mack-Cali strongly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

07:10
05/20/19
05/20
07:10
05/20/19
07:10
General news
Oil prices down from highs over USD 63 »

Oil prices down from…

ZAYO

Zayo Group

$32.70

-0.09 (-0.27%)

07:10
05/20/19
05/20
07:10
05/20/19
07:10
Downgrade
Zayo Group rating change  »

Zayo Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TSLA

Tesla

$211.02

-17.56 (-7.68%)

07:09
05/20/19
05/20
07:09
05/20/19
07:09
Recommendations
Tesla analyst commentary  »

Tesla price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

ALNY

Alnylam

$67.48

-1.52 (-2.20%)

, MDCO

The Medicines Co.

$33.01

-0.19 (-0.57%)

07:08
05/20/19
05/20
07:08
05/20/19
07:08
Recommendations
Alnylam, The Medicines Co. analyst commentary  »

Alnylam partner presented…

ALNY

Alnylam

$67.48

-1.52 (-2.20%)

MDCO

The Medicines Co.

$33.01

-0.19 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

SPTN

SpartanNash

$14.94

-0.27 (-1.78%)

07:07
05/20/19
05/20
07:07
05/20/19
07:07
Earnings
SpartanNash reaffirms FY19 adjusted EPS view $1.20-$1.50, consensus $1.69 »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 22

    May

CGEN

Compugen

$3.45

0.01 (0.29%)

, BMY

Bristol-Myers

$46.84

-0.28 (-0.59%)

07:07
05/20/19
05/20
07:07
05/20/19
07:07
Hot Stocks
Compugen doses first patient in Phase 1 COM701/Opdivo study »

Compugen (CGEN) announced…

CGEN

Compugen

$3.45

0.01 (0.29%)

BMY

Bristol-Myers

$46.84

-0.28 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 20

    May

  • 29

    May

  • 31

    May

TRK

Speedway Motorsports

$18.14

-0.035 (-0.19%)

07:06
05/20/19
05/20
07:06
05/20/19
07:06
Hot Stocks
Speedway Motorsports retains advisor to consider going private proposal »

Speedway Motorsports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$104.76

-2.98 (-2.77%)

07:05
05/20/19
05/20
07:05
05/20/19
07:05
Recommendations
Xilinx analyst commentary at Nomura Instinet »

U.S. action against…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTEC

Intec Pharma

$5.29

-0.07 (-1.31%)

07:05
05/20/19
05/20
07:05
05/20/19
07:05
Hot Stocks
Intec Pharma granted European patent »

Intec Pharma announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:05
05/20/19
05/20
07:05
05/20/19
07:05
General news
Tech sector weighs on global stock markets »

Tech sector weighs on…

SPTN

SpartanNash

$14.94

-0.27 (-1.78%)

07:04
05/20/19
05/20
07:04
05/20/19
07:04
Hot Stocks
SpartanNash sees over $20M in annual run rate cost savings over next 24 months »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 22

    May

ZAYO

Zayo Group

$32.70

-0.09 (-0.27%)

07:04
05/20/19
05/20
07:04
05/20/19
07:04
Downgrade
Zayo Group rating change  »

Zayo Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

VFF

Village Farms

$13.33

-0.47 (-3.41%)

07:04
05/20/19
05/20
07:04
05/20/19
07:04
Hot Stocks
Village Farms: Pure Sunfarms receives SPL from Health Canada »

Village Farms announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$24.67

0.01 (0.04%)

07:03
05/20/19
05/20
07:03
05/20/19
07:03
Hot Stocks
KKR, Western Natural Resources form partnership to pursue oil, gas investments »

KKR and Western Natural…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

SPTN

SpartanNash

$14.94

-0.27 (-1.78%)

07:03
05/20/19
05/20
07:03
05/20/19
07:03
Earnings
SpartanNash reports Q1 adjusted EPS 24c, consensus 34c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 22

    May

LOW

Lowe's

$109.00

0.11 (0.10%)

07:02
05/20/19
05/20
07:02
05/20/19
07:02
Hot Stocks
Lowe's acquires Retail Analytics platform from Boomerang Commerce »

Lowe's announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 31

    May

TOO

Teekay Offshore Partners

$1.16

-0.05 (-4.13%)

, BBU

Brookfield Business Partners

$38.53

-0.29 (-0.75%)

07:01
05/20/19
05/20
07:01
05/20/19
07:01
Hot Stocks
Teekay Offshore receives unsolicited offer from Brookfield Business Partners »

Teekay Offshore Partners…

TOO

Teekay Offshore Partners

$1.16

-0.05 (-4.13%)

BBU

Brookfield Business Partners

$38.53

-0.29 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.